Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1993 1
1994 11
2000 3
2001 5
2003 1
2004 1
2006 29
2010 2
2011 1
2012 8
2013 7
2014 3
2015 1
2016 1
2017 1
2018 8
2019 288
2020 94319
2021 141452
2022 130888
2023 89064
2024 26302
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

428,897 results

Results by year

Filters applied: . Clear all
Page 1
The laboratory investigation, management, and infection prevention and control of Candida auris: a narrative review to inform the 2024 national guidance update in England.
Jones CR, Neill C, Borman AM, Budd EL, Cummins M, Fry C, Guy RL, Jeffery K, Johnson EM, Manuel R, Mirfenderesky M, Moore G, Patel B, Schelenz S, Staniforth K, Taori SK, Brown CS. Jones CR, et al. J Med Microbiol. 2024 May;73(5). doi: 10.1099/jmm.0.001820. J Med Microbiol. 2024. PMID: 38771623
This review provides an update on epidemiology, the impact of the COVID-19 pandemic, risk factors, identification and typing, resistance profiles, treatment, detection of colonisation, and infection prevention and control measures for C. auris. ...
This review provides an update on epidemiology, the impact of the COVID-19 pandemic, risk factors, identification and typing, …
Out-of-Hospital Cardiac Arrest Before and During the COVID-19 Pandemic in Hong Kong: Registry-Based Study From 2017 to 2023.
Xu RH, Sun R, Fu SN. Xu RH, et al. JMIR Public Health Surveill. 2024 May 21;10:e56054. doi: 10.2196/56054. JMIR Public Health Surveill. 2024. PMID: 38771620
BACKGROUND: The COVID-19 pandemic has exerted a significant toll on individual health and the efficacy of health care systems. ...There was a correlation between the development of OHCA and the prevalence of COVID-19 in HK. CONCLUSIONS: The COVID
BACKGROUND: The COVID-19 pandemic has exerted a significant toll on individual health and the efficacy of health care systems. …
Racial and Ethnic Disparities in COVID-19 Mortality.
Sumibcay JRC, Kunichoff D, Bassett MT. Sumibcay JRC, et al. JAMA Netw Open. 2024 May 1;7(5):e2411656. doi: 10.1001/jamanetworkopen.2024.11656. JAMA Netw Open. 2024. PMID: 38771580
This cross-sectional study examines racial and ethnic differences in COVID-19 mortality in the United States across 4 case surges between February 2020 and September 2023....
This cross-sectional study examines racial and ethnic differences in COVID-19 mortality in the United States across 4 case sur …
Hospitalizations for Chronic Obstructive Pulmonary Disease Exacerbation During COVID-19.
Bourdin A, Ahmed E, Vachier I, Roche N, Pissarra J, Malafaye N, Molinari N. Bourdin A, et al. JAMA Netw Open. 2024 May 1;7(5):e2412383. doi: 10.1001/jamanetworkopen.2024.12383. JAMA Netw Open. 2024. PMID: 38771579
This cross-sectional study investigates changes in the number of chronic obstructive pulmonary disease (COPD)-related admissions before, during, and after the COVID-19 pandemic in France....
This cross-sectional study investigates changes in the number of chronic obstructive pulmonary disease (COPD)-related admissions before, dur …
A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19.
Liu WD, Feng PH, Cheng CY, Chou CL, Lee CH, Lu MC, Liu PY, Lee MH, Liao CH, Chen MC, Chen CP, Hsu SF, Tzeng YT, Lin YC, Ou TY, Qin A, Tsai CY, Shih WJ, Lee KY, Sheng WH. Liu WD, et al. Infect Dis Ther. 2024 May 21. doi: 10.1007/s40121-024-00992-5. Online ahead of print. Infect Dis Ther. 2024. PMID: 38771550
This clinical study aimed to evaluate its antiviral efficacy of ropeginterferon alfa-2b against SARS-CoV-2 infection. METHODS: This is a multicenter, randomized, open-label study. Adult patients with confirmed SARS-CoV-2 infection with in …
This clinical study aimed to evaluate its antiviral efficacy of ropeginterferon alfa-2b against SARS-CoV-2 infection. M …
Differential Cytokine Responses of APOE3 and APOE4 Blood-brain Barrier Cell Types to SARS-CoV-2 Spike Proteins.
Chaves JCS, Milton LA, Stewart R, Senapati T, Rantanen LM, Wasielewska JM, Lee S, Hernández D, McInnes L, Quek H, Pébay A, Donnelly PS, White AR, Oikari LE. Chaves JCS, et al. J Neuroimmune Pharmacol. 2024 May 21;19(1):22. doi: 10.1007/s11481-024-10127-9. J Neuroimmune Pharmacol. 2024. PMID: 38771543
SARS-CoV-2 spike proteins have been shown to cross the blood-brain barrier (BBB) in mice and affect the integrity of human BBB cell models. However, the effects of SARS-CoV-2 spike proteins in relation to sporadic, late onset, Alzheimer's
SARS-CoV-2 spike proteins have been shown to cross the blood-brain barrier (BBB) in mice and affect the integrity of hu
An overview of the efficacy of inhaled curcumin: a new mode of administration for an old molecule.
Rastegar-Pouyani N, Dongsar TS, Ataei M, Hassani S, Gumpricht E, Kesharwani P, Sahebkar A. Rastegar-Pouyani N, et al. Expert Opin Drug Deliv. 2024 May 21. doi: 10.1080/17425247.2024.2358880. Online ahead of print. Expert Opin Drug Deliv. 2024. PMID: 38771504 Review.
Also, application of the disclosed intervention in the clinical management of COVID-19 and Alzheimer's Disease has been discussed. EXPERT OPINION: In this portion, the potential of inhalable nanocurcumin in addressing various medical conditions along with ongoing ad …
Also, application of the disclosed intervention in the clinical management of COVID-19 and Alzheimer's Disease has been discus …
A microcosting approach for planning and implementing community-based mental health prevention program: what does it cost?
Roy S, Brown HS 3rd, Blinn LS, Narendorf SC, Hamilton JE. Roy S, et al. Health Econ Rev. 2024 May 21;14(1):35. doi: 10.1186/s13561-024-00510-w. Health Econ Rev. 2024. PMID: 38771498
This Program is among the first to use the Community Initiated Care (CIC) model in the US and is aimed at building community resilience and the capacity for communities to provide mental health support, particularly among those disproportionately impacted by COVID-19
This Program is among the first to use the Community Initiated Care (CIC) model in the US and is aimed at building community resilience and …
Photostability and photodynamic antimicrobial profile of dye extracts from four (4) plants: prospects for eco-friendly low-cost food disinfection and topical biomedical applications.
Majiya H, Adamu A, Galstyan A. Majiya H, et al. Photochem Photobiol Sci. 2024 May 21. doi: 10.1007/s43630-024-00585-8. Online ahead of print. Photochem Photobiol Sci. 2024. PMID: 38771468
In this study, photostability and photodynamic antimicrobial performance of dye extracts from Hibiscus sabdariffa (HS) calyces, Sorghum bicolor (SB) leaf sheaths, Lawsonia inermis (LI) leaves and Curcuma longa (CL) roots were investigated in Acetate-HCl (AH) Buffer (pH 4.6), Tris …
In this study, photostability and photodynamic antimicrobial performance of dye extracts from Hibiscus sabdariffa (HS) calyces, Sorghum bico …
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Lahmer T, Salmanton-García J, Marchesi F, El-Ashwah S, Nucci M, Besson C, Itri F, Jaksic O, Čolović N, Weinbergerová B, Seval GC, Adžić-Vukičević T, Szotkowski T, Sili U, Dargenio M, van Praet J, van Doesum J, Schönlein M, Ráčil Z, Žák P, Poulsen CB, Magliano G, Jiménez M, Bonuomo V, Piukovics K, Dragonetti G, Demirkan F, Blennow O, Valković T, Gomes Da Silva M, Maertens J, Glenthøj A, Fernández N, Bergantim R, Verga L, Petzer V, Omrani AS, Méndez GA, Machado M, Ledoux MP, Bailén R, Duarte RF, Del Principe MI, Farina F, Martín-Pérez S, Dávila-Valls J, Marchetti M, Bilgin YM, Fracchiolla NS, Cattaneo C, Espigado I, Cordoba R, Collins GP, Labrador J, Falces-Romero I, Prezioso L, Meers S, Passamonti F, Buquicchio C, López-García A, Kulasekararaj A, Ormazabal-Vélez I, Cuccaro A, Garcia-Vidal C, Busca A, Navrátil M, de Jonge N, Biernat MM, Guidetti A, Abu-Zeinah G, Samarkos M, Anastasopoulou A, de Ramón C, González-López TJ, Hoenigl M, Finizio O, Pinczés LI, Ali N, Vena A, Tascini C, Stojanoski Z, Merelli M, Emarah Z, Kohn M, Barać A, Mladenović M, Mišković B, Ilhan O, Çolak GM, Čerňan M, Gräfe SK, Ammatuna E, Hanakova M, Víšek B, Cabirta A, Nordlander A, Nunes Rodrigues R, Hersby DS, … See abstract for full author list ➔ Lahmer T, et al. Infection. 2024 May 21. doi: 10.1007/s15010-024-02240-x. Online ahead of print. Infection. 2024. PMID: 38771466 No abstract available.
Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols.
Baig AM, Rosko S, Jaeger B, Gerlach J, Rausch H. Baig AM, et al. Inflammopharmacology. 2024 May 21. doi: 10.1007/s10787-024-01483-2. Online ahead of print. Inflammopharmacology. 2024. PMID: 38771409 Review.
As instances of long COVID manifest by repeated infections of SARS-CoV-2 and genetic predisposition, a detailed understanding in this regard is needed. ...The paper introduces a unified theory of long COVID, detailing a novel pathophysiological framework that …
As instances of long COVID manifest by repeated infections of SARS-CoV-2 and genetic predisposition, a detailed underst …
Audio Highlights.
[No authors listed] [No authors listed] JAMA. 2024 May 21;331(19):e2318290. doi: 10.1001/jama.2023.18290. Epub 2024 May 21. JAMA. 2024. PMID: 38771328 No abstract available.
Rapid Detection of M. tuberculosis and Its Resistance to Rifampicin and Isoniazid with the mfloDx™ MDR-TB test.
Ramasubban G, Michael JS, Gupta R, Venkatesan M, Beauton AP, Hoffner S, Asalapuram P. Ramasubban G, et al. Int J Mycobacteriol. 2024 Jan 1;13(1):91-95. doi: 10.4103/ijmy.ijmy_21_24. Epub 2024 Mar 15. Int J Mycobacteriol. 2024. PMID: 38771285
METHODS: EMPE Diagnostics has developed a multiplex molecular diagnostic platform called mfloDx by combining nucleotide-specific padlock probe-dependent rolling circle amplification with sensitive lateral flow biosensors, providing visual signals, similar to a COVID-19
METHODS: EMPE Diagnostics has developed a multiplex molecular diagnostic platform called mfloDx by combining nucleotide-specific padlock pro …
Tuberculosis Coinfection among COVID-19 Patients: Clinical Presentation and Mortality in a Tertiary Lung Hospital in Indonesia.
Muflihah H, Yulianto FA, Rina, Sampurno E, Ferdiana A, Rahimah SB. Muflihah H, et al. Int J Mycobacteriol. 2024 Jan 1;13(1):58-64. doi: 10.4103/ijmy.ijmy_19_24. Epub 2024 Mar 15. Int J Mycobacteriol. 2024. PMID: 38771281
BACKGROUND: Tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are the top two killers of infectious disease. ...COVID-19 patients without TB were randomly selected for the control group. ...
BACKGROUND: Tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are the top two killers of infectious disease. .. …
Two Difficult Pandemics: Tuberculosis and COVID-19.
Katran ZY, Babalık A, Türkar A, Demir FK, Çakmak B. Katran ZY, et al. Int J Mycobacteriol. 2024 Jan 1;13(1):28-33. doi: 10.4103/ijmy.ijmy_189_23. Epub 2024 Mar 15. Int J Mycobacteriol. 2024. PMID: 38771276
BACKGROUND: The coinfection of Mycobacterium tuberculosis and SARS-CoV-2 is called tuberculosis and COVID-19 coinfection (TB-COVID-19). ...All coinfected patients whose COVID-19 polymerase chain reaction results were …
BACKGROUND: The coinfection of Mycobacterium tuberculosis and SARS-CoV-2 is called tuberculosis and COVID-19
A Study on the Epidemiology of COVID-19-Related Guillain-Barre Syndrome in the United States.
Sharma A, Sharma A, Soubani AO. Sharma A, et al. J Clin Neuromuscul Dis. 2024 Jun 1;25(4):178-183. doi: 10.1097/CND.0000000000000480. J Clin Neuromuscul Dis. 2024. PMID: 38771227
RESULTS: In total, 13,705 GBS admissions were recorded nationwide in 2020; of these, 1155 (8.43%) were associated with COVID-19. The frequency of GBS in COVID-19 admissions was 0.07%, compared with 0.08% in non-COVID-19 admissions (P = 0. …
RESULTS: In total, 13,705 GBS admissions were recorded nationwide in 2020; of these, 1155 (8.43%) were associated with COVID-19
Coding of Childhood Psychiatric and Neurodevelopmental Disorders in Electronic Health Records of a Large Integrated Health Care System: Validation Study.
Shi JM, Chiu VY, Avila CC, Lewis S, Park D, Peltier MR, Getahun D. Shi JM, et al. JMIR Ment Health. 2024 May 14;11:e56812. doi: 10.2196/56812. JMIR Ment Health. 2024. PMID: 38771217
OBJECTIVES: We aimed to evaluate the accuracy of coding related to pediatric mental, emotional, and behavioral disorders in a large integrated health care system's electronic health records (EHRs) and compare the coding quality before and after the implementation of the Internati …
OBJECTIVES: We aimed to evaluate the accuracy of coding related to pediatric mental, emotional, and behavioral disorders in a large integrat …
Evaluating adherence to American Diabetes Association standards of care in diabetes and impacts of social determinants of health on patients at two nurse practitioner-owned clinics.
Tuohy CA, Liziewski KE, White PA, Wright WL. Tuohy CA, et al. J Am Assoc Nurse Pract. 2024 May 21. doi: 10.1097/JXX.0000000000001026. Online ahead of print. J Am Assoc Nurse Pract. 2024. PMID: 38771202
BACKGROUND: The COVID-19 pandemic created barriers in the management of type 2 diabetes mellitus (T2DM) and worsened social determinants of health (SDOH). ...LOCAL PROBLEM: A1C values have increased at the practice, especially since COVID-19. The pract …
BACKGROUND: The COVID-19 pandemic created barriers in the management of type 2 diabetes mellitus (T2DM) and worsened social de …
428,897 results
You have reached the last available page of results. Please see the User Guide for more information.